PCH
Polar Capital Holdings Portfolio holdings
AUM
$19.1B
1-Year Return
55.52%
This Quarter Return
+16.73%
1 Year Return
+55.52%
3 Year Return
+234.94%
5 Year Return
–
10 Year Return
–
AUM
$13.6B
AUM Growth
+$1.09B
(+8.7%)
Cap. Flow
-$470M
Cap. Flow
% of AUM
-3.44%
Top 10 Holdings %
Top 10 Hldgs %
26.38%
Holding
338
New
29
Increased
113
Reduced
120
Closed
45
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$100M |
| 2 |
Uber
UBER
|
$92.9M |
| 3 |
Baidu
BIDU
|
$87M |
| 4 |
ON Semiconductor
ON
|
$70.2M |
| 5 |
Inspire Medical Systems
INSP
|
$62.9M |
Top Sells
| 1 |
Arch Capital
ACGL
|
$80.1M |
| 2 |
Microsoft
MSFT
|
$75.1M |
| 3 |
Penumbra
PEN
|
$63.4M |
| 4 |
Becton Dickinson
BDX
|
$63M |
| 5 |
BILL Holdings
BILL
|
$62.3M |
Sector Composition
| 1 | Technology | 40.68% |
| 2 | Healthcare | 23.35% |
| 3 | Financials | 18.62% |
| 4 | Communication Services | 7% |
| 5 | Consumer Discretionary | 5.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Alibaba
BABA
$323B
| $86.9M | 0.56% |
850,581
-187,615
| -18% | -$19.2M |
|
52
Progressive
PGR
$143B
| $85.8M | 0.56% |
600,000
-75,000
| -11% | -$10.7M |
|
53
Celldex Therapeutics
CLDX
$1.52B
| $81.6M | 0.53% |
2,267,989
+717,989
| +46% | +$25.8M |
|
54
Alkermes
ALKS
$4.94B
| $81.4M | 0.53% |
2,888,016
+636,574
| +28% | +$17.9M |
|
55
Incyte
INCY
$16.9B
| $79.5M | 0.52% |
1,100,000
-135,072
| -11% | -$9.76M |
|
56
Salesforce
CRM
$239B
| $77.6M | 0.5% |
388,609
-59,033
| -13% | -$11.8M |
|
57
Reinsurance Group of America
RGA
$12.8B
| $75.7M | 0.49% |
570,000
-167,500
| -23% | -$22.2M |
|
58
Acadia Healthcare
ACHC
$2.19B
| $75.2M | 0.49% |
1,040,304
-37,579
| -3% | -$2.72M |
|
59
Roblox
RBLX
$88.5B
| $73.6M | 0.48% |
1,637,331
+596,443
| +57% | +$26.8M |
|
60
United Therapeutics
UTHR
$18.1B
| $72.6M | 0.47% |
324,075
-818
| -0.3% | -$183K |
|
61
First Solar
FSLR
$22B
| $71.8M | 0.47% |
330,311
+151,011
| +84% | +$32.8M |
|
62
Bio-Rad Laboratories Class A
BIO
$8B
| $70.9M | 0.46% |
147,907
+37,863
| +34% | +$18.1M |
|
63
Biogen
BIIB
$20.6B
| $69.5M | 0.45% |
250,000
+100,000
| +67% | +$27.8M |
|
64
Marvell Technology
MRVL
$54.6B
| $65.7M | 0.43% |
1,518,220
-1,025,337
| -40% | -$44.4M |
|
65
Confluent
CFLT
$6.67B
| $64.9M | 0.42% |
2,698,102
+1,975,784
| +274% | +$47.6M |
|
66
Exelixis
EXEL
$10.2B
| $64.5M | 0.42% |
3,320,898
+750,000
| +29% | +$14.6M |
|
|
67
Inspire Medical Systems
INSP
$2.56B
| $62.9M | 0.41% |
+268,650
| New | +$62.9M |
|
68
Boston Scientific
BSX
$159B
| $62.7M | 0.41% |
1,253,941
-960,042
| -43% | -$48M |
|
69
Johnson & Johnson
JNJ
$430B
| $62.6M | 0.41% |
403,865
+42,679
| +12% | +$6.62M |
|
70
Alnylam Pharmaceuticals
ALNY
$59.2B
| $62.5M | 0.41% |
311,918
+14,418
| +5% | +$2.89M |
|
71
HCA Healthcare
HCA
$98.5B
| $61.6M | 0.4% |
233,642
+149,378
| +177% | +$39.4M |
|
72
Berkshire Hathaway Class B
BRK.B
$1.08T
| $61.5M | 0.4% |
199,084
-120,658
| -38% | -$37.3M |
|
73
Option Care Health
OPCH
$4.72B
| $61.2M | 0.4% |
1,927,276
-382,035
| -17% | -$12.1M |
|
74
SiTime
SITM
$6.1B
| $56.8M | 0.37% |
399,281
-110,899
| -22% | -$15.8M |
|
75
TripAdvisor
TRIP
$2.05B
| $55.8M | 0.36% |
2,809,974
+625,225
| +29% | +$12.4M |
|